NEW COMPOUNDS ACTING AS ERK INACTIVATORS

FIELD: chemistry. ^ SUBSTANCE: invention refers to new indazole derivants with the formula (1.0) or to their pharmaceutically acceptable salts and isomerides that act as inactivators in relation to ERK2. In formula (1.0): meanings of the chemical groups Q, R1, R2 are given in the invention formula....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DESAI JAGDISH, KSIAO LI, SHIKH NENG-JANG, ZHU KH'JU, KHRUZA ALAN, SAN ROBERT, SHIPPS DZHERAL'D V. ML, DONG JUKHAO, MEHDISON VINSENT S, SAMATAR AKHMED, TSUI KHONUNG, CHELEBI AZIM A, KELLI DZHOZEF, BOGA SOBKHANA BABU, VU JIDZHI, DOLL RONAL'D, VANG TONG, VANG DZHEJMS, NAN JANG, DENG JONGKI, PALIVAL SUNIL, KUPER ALAN, SIDDIKI M. ARSHAD
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DESAI JAGDISH
KSIAO LI
SHIKH NENG-JANG
ZHU KH'JU
KHRUZA ALAN
SAN ROBERT
SHIPPS DZHERAL'D V. ML
DONG JUKHAO
MEHDISON VINSENT S
SAMATAR AKHMED
TSUI KHONUNG
CHELEBI AZIM A
KELLI DZHOZEF
BOGA SOBKHANA BABU
VU JIDZHI
DOLL RONAL'D
VANG TONG
VANG DZHEJMS
NAN JANG
DENG JONGKI
PALIVAL SUNIL
KUPER ALAN
SIDDIKI M. ARSHAD
description FIELD: chemistry. ^ SUBSTANCE: invention refers to new indazole derivants with the formula (1.0) or to their pharmaceutically acceptable salts and isomerides that act as inactivators in relation to ERK2. In formula (1.0): meanings of the chemical groups Q, R1, R2 are given in the invention formula. The invention also refers to the pharmaceutical composition containing the mentioned compounds and to application of the compounds with the formula (1.0) for production of crude drugs used in malignant growth treatment. ^ EFFECT: application of the compounds for production of crude drugs used in malignant growth treatment. ^ 65 cl, 611 ex, 27 tbl Изобретение относится к новым производным индазола формулы (1.0) или их фармацевтически приемлемым солям и изомерам, которые обладают ингибирующей активностью в отношении ЕКК2. В формуле (1.0): ! ! значения радикалов Q, R1, R2 приведены в формуле изобретения. Изобретение также относится к фармацевтической композиции, содержащей указанные соединения, и к применению соединений формулы (1.0) для производства лекарственного средства для лечения злокачественной опухоли. 3 н. и 62 з.п. ф-лы, 27 табл.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2442778C9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2442778C9</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2442778C93</originalsourceid><addsrcrecordid>eNrjZNDwcw1XcPb3DfAP9XMJVnB0DvH0c1dwDFZwDfJW8PQD8cMcQ_yDgnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxQqJGJiZG5uYWzpTERSgDIhiP4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEW COMPOUNDS ACTING AS ERK INACTIVATORS</title><source>esp@cenet</source><creator>DESAI JAGDISH ; KSIAO LI ; SHIKH NENG-JANG ; ZHU KH'JU ; KHRUZA ALAN ; SAN ROBERT ; SHIPPS DZHERAL'D V. ML ; DONG JUKHAO ; MEHDISON VINSENT S ; SAMATAR AKHMED ; TSUI KHONUNG ; CHELEBI AZIM A ; KELLI DZHOZEF ; BOGA SOBKHANA BABU ; VU JIDZHI ; DOLL RONAL'D ; VANG TONG ; VANG DZHEJMS ; NAN JANG ; DENG JONGKI ; PALIVAL SUNIL ; KUPER ALAN ; SIDDIKI M. ARSHAD</creator><creatorcontrib>DESAI JAGDISH ; KSIAO LI ; SHIKH NENG-JANG ; ZHU KH'JU ; KHRUZA ALAN ; SAN ROBERT ; SHIPPS DZHERAL'D V. ML ; DONG JUKHAO ; MEHDISON VINSENT S ; SAMATAR AKHMED ; TSUI KHONUNG ; CHELEBI AZIM A ; KELLI DZHOZEF ; BOGA SOBKHANA BABU ; VU JIDZHI ; DOLL RONAL'D ; VANG TONG ; VANG DZHEJMS ; NAN JANG ; DENG JONGKI ; PALIVAL SUNIL ; KUPER ALAN ; SIDDIKI M. ARSHAD</creatorcontrib><description>FIELD: chemistry. ^ SUBSTANCE: invention refers to new indazole derivants with the formula (1.0) or to their pharmaceutically acceptable salts and isomerides that act as inactivators in relation to ERK2. In formula (1.0): meanings of the chemical groups Q, R1, R2 are given in the invention formula. The invention also refers to the pharmaceutical composition containing the mentioned compounds and to application of the compounds with the formula (1.0) for production of crude drugs used in malignant growth treatment. ^ EFFECT: application of the compounds for production of crude drugs used in malignant growth treatment. ^ 65 cl, 611 ex, 27 tbl Изобретение относится к новым производным индазола формулы (1.0) или их фармацевтически приемлемым солям и изомерам, которые обладают ингибирующей активностью в отношении ЕКК2. В формуле (1.0): ! ! значения радикалов Q, R1, R2 приведены в формуле изобретения. Изобретение также относится к фармацевтической композиции, содержащей указанные соединения, и к применению соединений формулы (1.0) для производства лекарственного средства для лечения злокачественной опухоли. 3 н. и 62 з.п. ф-лы, 27 табл.</description><language>eng ; rus</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120810&amp;DB=EPODOC&amp;CC=RU&amp;NR=2442778C9$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120810&amp;DB=EPODOC&amp;CC=RU&amp;NR=2442778C9$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DESAI JAGDISH</creatorcontrib><creatorcontrib>KSIAO LI</creatorcontrib><creatorcontrib>SHIKH NENG-JANG</creatorcontrib><creatorcontrib>ZHU KH'JU</creatorcontrib><creatorcontrib>KHRUZA ALAN</creatorcontrib><creatorcontrib>SAN ROBERT</creatorcontrib><creatorcontrib>SHIPPS DZHERAL'D V. ML</creatorcontrib><creatorcontrib>DONG JUKHAO</creatorcontrib><creatorcontrib>MEHDISON VINSENT S</creatorcontrib><creatorcontrib>SAMATAR AKHMED</creatorcontrib><creatorcontrib>TSUI KHONUNG</creatorcontrib><creatorcontrib>CHELEBI AZIM A</creatorcontrib><creatorcontrib>KELLI DZHOZEF</creatorcontrib><creatorcontrib>BOGA SOBKHANA BABU</creatorcontrib><creatorcontrib>VU JIDZHI</creatorcontrib><creatorcontrib>DOLL RONAL'D</creatorcontrib><creatorcontrib>VANG TONG</creatorcontrib><creatorcontrib>VANG DZHEJMS</creatorcontrib><creatorcontrib>NAN JANG</creatorcontrib><creatorcontrib>DENG JONGKI</creatorcontrib><creatorcontrib>PALIVAL SUNIL</creatorcontrib><creatorcontrib>KUPER ALAN</creatorcontrib><creatorcontrib>SIDDIKI M. ARSHAD</creatorcontrib><title>NEW COMPOUNDS ACTING AS ERK INACTIVATORS</title><description>FIELD: chemistry. ^ SUBSTANCE: invention refers to new indazole derivants with the formula (1.0) or to their pharmaceutically acceptable salts and isomerides that act as inactivators in relation to ERK2. In formula (1.0): meanings of the chemical groups Q, R1, R2 are given in the invention formula. The invention also refers to the pharmaceutical composition containing the mentioned compounds and to application of the compounds with the formula (1.0) for production of crude drugs used in malignant growth treatment. ^ EFFECT: application of the compounds for production of crude drugs used in malignant growth treatment. ^ 65 cl, 611 ex, 27 tbl Изобретение относится к новым производным индазола формулы (1.0) или их фармацевтически приемлемым солям и изомерам, которые обладают ингибирующей активностью в отношении ЕКК2. В формуле (1.0): ! ! значения радикалов Q, R1, R2 приведены в формуле изобретения. Изобретение также относится к фармацевтической композиции, содержащей указанные соединения, и к применению соединений формулы (1.0) для производства лекарственного средства для лечения злокачественной опухоли. 3 н. и 62 з.п. ф-лы, 27 табл.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDwcw1XcPb3DfAP9XMJVnB0DvH0c1dwDFZwDfJW8PQD8cMcQ_yDgnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxQqJGJiZG5uYWzpTERSgDIhiP4</recordid><startdate>20120810</startdate><enddate>20120810</enddate><creator>DESAI JAGDISH</creator><creator>KSIAO LI</creator><creator>SHIKH NENG-JANG</creator><creator>ZHU KH'JU</creator><creator>KHRUZA ALAN</creator><creator>SAN ROBERT</creator><creator>SHIPPS DZHERAL'D V. ML</creator><creator>DONG JUKHAO</creator><creator>MEHDISON VINSENT S</creator><creator>SAMATAR AKHMED</creator><creator>TSUI KHONUNG</creator><creator>CHELEBI AZIM A</creator><creator>KELLI DZHOZEF</creator><creator>BOGA SOBKHANA BABU</creator><creator>VU JIDZHI</creator><creator>DOLL RONAL'D</creator><creator>VANG TONG</creator><creator>VANG DZHEJMS</creator><creator>NAN JANG</creator><creator>DENG JONGKI</creator><creator>PALIVAL SUNIL</creator><creator>KUPER ALAN</creator><creator>SIDDIKI M. ARSHAD</creator><scope>EVB</scope></search><sort><creationdate>20120810</creationdate><title>NEW COMPOUNDS ACTING AS ERK INACTIVATORS</title><author>DESAI JAGDISH ; KSIAO LI ; SHIKH NENG-JANG ; ZHU KH'JU ; KHRUZA ALAN ; SAN ROBERT ; SHIPPS DZHERAL'D V. ML ; DONG JUKHAO ; MEHDISON VINSENT S ; SAMATAR AKHMED ; TSUI KHONUNG ; CHELEBI AZIM A ; KELLI DZHOZEF ; BOGA SOBKHANA BABU ; VU JIDZHI ; DOLL RONAL'D ; VANG TONG ; VANG DZHEJMS ; NAN JANG ; DENG JONGKI ; PALIVAL SUNIL ; KUPER ALAN ; SIDDIKI M. ARSHAD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2442778C93</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DESAI JAGDISH</creatorcontrib><creatorcontrib>KSIAO LI</creatorcontrib><creatorcontrib>SHIKH NENG-JANG</creatorcontrib><creatorcontrib>ZHU KH'JU</creatorcontrib><creatorcontrib>KHRUZA ALAN</creatorcontrib><creatorcontrib>SAN ROBERT</creatorcontrib><creatorcontrib>SHIPPS DZHERAL'D V. ML</creatorcontrib><creatorcontrib>DONG JUKHAO</creatorcontrib><creatorcontrib>MEHDISON VINSENT S</creatorcontrib><creatorcontrib>SAMATAR AKHMED</creatorcontrib><creatorcontrib>TSUI KHONUNG</creatorcontrib><creatorcontrib>CHELEBI AZIM A</creatorcontrib><creatorcontrib>KELLI DZHOZEF</creatorcontrib><creatorcontrib>BOGA SOBKHANA BABU</creatorcontrib><creatorcontrib>VU JIDZHI</creatorcontrib><creatorcontrib>DOLL RONAL'D</creatorcontrib><creatorcontrib>VANG TONG</creatorcontrib><creatorcontrib>VANG DZHEJMS</creatorcontrib><creatorcontrib>NAN JANG</creatorcontrib><creatorcontrib>DENG JONGKI</creatorcontrib><creatorcontrib>PALIVAL SUNIL</creatorcontrib><creatorcontrib>KUPER ALAN</creatorcontrib><creatorcontrib>SIDDIKI M. ARSHAD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DESAI JAGDISH</au><au>KSIAO LI</au><au>SHIKH NENG-JANG</au><au>ZHU KH'JU</au><au>KHRUZA ALAN</au><au>SAN ROBERT</au><au>SHIPPS DZHERAL'D V. ML</au><au>DONG JUKHAO</au><au>MEHDISON VINSENT S</au><au>SAMATAR AKHMED</au><au>TSUI KHONUNG</au><au>CHELEBI AZIM A</au><au>KELLI DZHOZEF</au><au>BOGA SOBKHANA BABU</au><au>VU JIDZHI</au><au>DOLL RONAL'D</au><au>VANG TONG</au><au>VANG DZHEJMS</au><au>NAN JANG</au><au>DENG JONGKI</au><au>PALIVAL SUNIL</au><au>KUPER ALAN</au><au>SIDDIKI M. ARSHAD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEW COMPOUNDS ACTING AS ERK INACTIVATORS</title><date>2012-08-10</date><risdate>2012</risdate><abstract>FIELD: chemistry. ^ SUBSTANCE: invention refers to new indazole derivants with the formula (1.0) or to their pharmaceutically acceptable salts and isomerides that act as inactivators in relation to ERK2. In formula (1.0): meanings of the chemical groups Q, R1, R2 are given in the invention formula. The invention also refers to the pharmaceutical composition containing the mentioned compounds and to application of the compounds with the formula (1.0) for production of crude drugs used in malignant growth treatment. ^ EFFECT: application of the compounds for production of crude drugs used in malignant growth treatment. ^ 65 cl, 611 ex, 27 tbl Изобретение относится к новым производным индазола формулы (1.0) или их фармацевтически приемлемым солям и изомерам, которые обладают ингибирующей активностью в отношении ЕКК2. В формуле (1.0): ! ! значения радикалов Q, R1, R2 приведены в формуле изобретения. Изобретение также относится к фармацевтической композиции, содержащей указанные соединения, и к применению соединений формулы (1.0) для производства лекарственного средства для лечения злокачественной опухоли. 3 н. и 62 з.п. ф-лы, 27 табл.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2442778C9
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NEW COMPOUNDS ACTING AS ERK INACTIVATORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A14%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DESAI%20JAGDISH&rft.date=2012-08-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2442778C9%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true